×
About 545 results

ALLMedicine™ Hemolytic-uremic Syndrome Center

Research & Reviews  192 results

Hemolytic-Uremic Syndrome (HUS)
https://www.merckmanuals.com/professional/hematology-and-oncology/thrombocytopenia-and-platelet-dysfunction/hemolytic-uremic-syndrome-hus

Jun 1st, 2022 - Hemolytic-uremic syndrome (HUS) is an acute, fulminant disorder characterized by thrombocytopenia, microangiopathic hemolytic anemia, and acute kidney injury. HUS usually occurs in children following an infection, typically with Shiga toxin–produc...

Hemolytic-Uremic Syndrome (HUS)
https://www.merckmanuals.com/en-ca/professional/hematology-and-oncology/thrombocytopenia-and-platelet-dysfunction/hemolytic-uremic-syndrome-hus

Jun 1st, 2022 - Hemolytic-uremic syndrome (HUS) is an acute, fulminant disorder characterized by thrombocytopenia, microangiopathic hemolytic anemia, and acute kidney injury. HUS usually occurs in children following an infection, typically with Shiga toxin–produc...

Hemolytic-Uremic Syndrome (HUS)
https://www.merckmanuals.com/en-pr/professional/hematology-and-oncology/thrombocytopenia-and-platelet-dysfunction/hemolytic-uremic-syndrome-hus

Jun 1st, 2022 - Hemolytic-uremic syndrome (HUS) is an acute, fulminant disorder characterized by thrombocytopenia, microangiopathic hemolytic anemia, and acute kidney injury. HUS usually occurs in children following an infection, typically with Shiga toxin–produc...

Pediatric Hemolytic Uremic Syndrome
http://emedicine.medscape.com/article/982025-overview

May 25th, 2022 - Practice Essentials Hemolytic-uremic syndrome (HUS) was first described by Gasser in a German publication in 1955. Hemolytic-uremic syndrome consists of the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. [1]...

Pediatric Hemolytic Uremic Syndrome
https://emedicine.medscape.com/article/982025-print

May 25th, 2022 - Practice Essentials Hemolytic-uremic syndrome (HUS) was first described by Gasser in a German publication in 1955. Hemolytic-uremic syndrome consists of the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure.[1] ...

see more →

Clinicaltrials.gov  10 results

Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
https://clinicaltrials.gov/ct2/show/NCT01522183

Mar 16th, 2022 - The study will capture post-marketing safety data on patients treated with eculizumab or ravulizumab. Additionally, the study will collect information on the progression of disease in all patients.

Belatacept 3 Month Post Transplant Conversion Study
https://clinicaltrials.gov/ct2/show/NCT02213068

Sep 8th, 2021 - Immunosuppressive therapy with the calcineurin inhibitors (CNI) cyclosporine (CsA) and Tacrolimus (Tac), have radically changed the field of organ transplantation. Ironically, although extensively and effectively used for kidney transplantation an...

Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens
https://clinicaltrials.gov/ct2/show/NCT01653847

Mar 2nd, 2021 - Immunosuppressive therapy with the calcineurin inhibitors (CNI) Cyclosporine (CsA) and Tacrolimus (Tac), have radically changed the field of organ transplantation. Ironically, although extensively and effectively used for kidney transplantation an...

An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
https://clinicaltrials.gov/ct2/show/NCT01194973

May 30th, 2017 - The record Primary purpose is to assess the efficacy of eculizumab in adult patients with Atypical Hemolytic- Uremic Syndrome (aHUS) to control Thrombotic Microangiopathy (TMA) as characterized by thrombocytopenia, hemolysis and renal impairment.

Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS
https://clinicaltrials.gov/ct2/show/NCT00844428

Jul 23rd, 2015 - The purpose of this study is to determine whether eculizumab is safe and effective in the treatment of adolescent patients with plasma therapy-sensitive Atypical Hemolytic-Uremic Syndrome (aHUS).

see more →

News  16 results

High Responses Observed With Avelumab Added to Regimen for Metastatic Colorectal Cancer Does Not Translate to PFS
https://www.onclive.com/view/high-responses-observed-with-avelumab-added-to-regimen-for-metastatic-colorectal-cancer-does-not-translate-to-pfs

Dec 20th, 2020 - Meinolf Karthaus, MD A regimen of avelumab (Bavencio) and cetuximab (Erbitux) plus oxaliplatin, leucovorin, and 5-fluorouracil (5-FU; mFOLFOX6) in patients with RAS/BRAF-wildtype metastatic colorectal cancer induced a very high response rate but ...

Egypt prosecutor says e-coli was factor in deaths of British tourists
https://www.reuters.com/article/us-egypt-tourists/egypt-prosecutor-says-e-coli-was-factor-in-deaths-of-british-tourists-idUSKCN1LS2D8

Sep 12th, 2018 - CAIRO (Reuters) - Egypt’s public prosecutor said on Wednesday that e-coli bacteria were a factor in the deaths of two British tourists in the Red Sea resort of Hurghada last month. FILE PHOTO: A view of the Red Sea resort of Hurghada, Egypt, Augus...

E coli and Food Safety: It's a Jungle Out There
https://www.medscape.com/viewarticle/895308

Apr 23rd, 2018 - Foodborne illnesses are a substantial yet largely preventable health burden worldwide. We previously reviewed food safety in the United States[1] and harked back to the classic book, The Jungle, which portrayed the unsanitary conditions and practi...

E coli and Food Safety: It's a Jungle Out There
https://www.medscape.com/viewarticle/895308_1

Apr 23rd, 2018 - Foodborne illnesses are a substantial yet largely preventable health burden worldwide. We previously reviewed food safety in the United States[1] and harked back to the classic book, The Jungle, which portrayed the unsanitary conditions and practi...

A 60-Year-Old Woman With Chest and Abdominal Pain
https://reference.medscape.com/viewarticle/885533_4

Sep 19th, 2017 - Other causes of hemolytic anemia including medications, microangiopathic hemolytic anemia (MAHA), and infections (commonly malaria, babesiosis, nontyphoidal salmonella, E coli , HIV) should be ruled out.[1] This patient had a low likelihood of dru...

see more →